Intas Pharmaceuticals Limited Letrozole Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Letrozole Export Records India — #2 Exporter, 493 Shipments, $6.9M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Letrozole

India Pharmaceutical Trade Intelligence

$32.1M252 Suppliers117 CountriesHS 30049049

ExportsIndia → THAILAND48.3%India → UNITED STATES12.1%

ImportsSWITZERLAND → India$30.9K BELGIUM → India$7.4K

#1 Supplier: CIPLA LIMITED

Intas Pharmaceuticals Limited — Letrozole Exporter #2 | $7.2M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Letrozole Exporter Profile

Indian Pharmaceutical Exporter · #2 for Letrozole · $7.2M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #2 Indian exporter of Letrozole with $7.2M in export value and 493 verified shipments. Intas Pharmaceuticals Limited holds a 21.6% market share in Letrozole exports across 18 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Letrozole Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Letrozole export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Letrozole?

Country	Value	Shipments	Share
UNITED STATES	$2.3M	79	37.2%
UNITED KINGDOM	$1.5M	124	23.9%
NETHERLANDS	$620.1K	91	10.0%
CANADA	$418.0K	26

Who Are the Top Buyers of Letrozole from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
EVERSANA LIFE SCIENCES SERVICES,LLC	UNITED STATES	$1.3M	42
ACCORD UK	UNITED KINGDOM	$1.2M	49
EVERSANA LIFE SCIENCES SERVICES LLC	UNITED STATES	$786.0K	23
TO THE ORDER	UNITED KINGDOM	$475.1K	66
BROCACEF NL : HUB	NETHERLANDS	$212.3K	42
KRKA. D.D.	SLOVENIA	$201.1K	18
ACCORD HEALTHCARE INC	CANADA	$200.1K	10
ACCORD HEALTHCARE C/O QESTMED (PTY)	SOUTH AFRICA	$150.0K	3
ACCORD HEALTHCARE SINGLE MEMBER SA	GREECE	$117.2K	12
JUST PHARMA SRL	ITALY	$114.7K	12

Intas Pharmaceuticals Limited supplies Letrozole to 56 buyers globally. The largest buyer is EVERSANA LIFE SCIENCES SERVICES,LLC (UNITED STATES), followed by ACCORD UK (UNITED KINGDOM) and EVERSANA LIFE SCIENCES SERVICES LLC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Letrozole Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHARMA DRUGS & MEDI LETROZOLE TAB USP 2.	$848.1K	28
PHARMA DRUGS & MEDI LETROZOLE 2.5MG 2X14	$372.6K	17
PHR DRUGS&MEDI LETROZOLE TAB USP 2.5 MG	$285.0K	6
PHR DRUGS & MEDI LETROZOLE TAB USP 2.5 M	$177.7K	4
PH.DRU.& MED.: LETROZOLE TABLETS 2.5MG (	$163.6K	14
PHARMA DRUGS MEDI LETROZOLE TAB USP 2 5 MG 90T US ACCO AS PER INVOICE	$149.8K	5
PHARMA DRUG&MED:LETROZOLE 2.5MG 2X14T G1	$135.7K	5
PHARMA DRUGS & MEDI LETROZOLE TAB USP 2.5 MG 30TUS-ACCO AS PER DOCUMENT	$131.3K	3
PHARMA DRUGS & MEDI LETROZOLE TAB USP 2.5 MG 90TUS-ACCO AS PER DOCUMENT	$126.1K	3
PHARMA DRUGS & MEDI LETROZOLE TAB USP 2.5 MG 90T(US-ACCO AS PER INVOICE	$101.0K	5

Intas Pharmaceuticals Limited exports 182 distinct Letrozole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA DRUGS & MEDI LETROZOLE TAB USP 2. with 28 shipments worth $848.1K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Intas Pharmaceuticals Limited Compare to Nearest Letrozole Exporters?

Exporters ranked immediately above and below #2 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	INTAS PHARMACEUTICALS LIMITED ★	$6.9M	493	18	$14.0K
1	CIPLA LIMITED	$4.1M	82	6	$50.0K
3	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$2.4M	56	8	$43.3K

Intas Pharmaceuticals Limited ranks #2 among 252 Indian Letrozole exporters. Average shipment value of $14.0K compared to the market average of $74.0K. The closest competitors by value are CIPLA LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED.

Which Indian Ports Ship Letrozole Exports?

Port	Shipments	% Share
SAHAR AIR	404	19.1%
SAHAR AIR CARGO ACC (INBOM4)	393	18.6%
MUNDRA SEA (INMUN1)	109	5.2%
AHEMDABAD AIR ACC (INAMD4)	107	5.1%
MUNDRA SEA	102	4.8%
DELHI AIR CARGO ACC (INDEL4)	100	4.7%
Bombay Air	99	4.7%
HYDERABAD AIR	89	4.2%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Letrozole Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Letrozole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 512 individual customs records matching Intas Pharmaceuticals Limited exporting Letrozole, covering 182 formulations to 19 countries via 56 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 117+ countries, 508+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Letrozole

Letrozole

Intas Pharmaceuticals Limited — Letrozole Exporter Profile

Intas Pharmaceuticals Limited — Letrozole Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Letrozole?

Who Are the Top Buyers of Letrozole from Intas Pharmaceuticals Limited?

What Is India's Total Letrozole Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Letrozole Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Letrozole Exporters?

What Letrozole Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Letrozole to Key Markets

United States — FDA

United Kingdom — MHRA

How Does Intas Pharmaceuticals Limited Compare to Nearest Letrozole Exporters?

Which Indian Ports Ship Letrozole Exports?

What Other Advanced Oncology Products Does Intas Pharmaceuticals Limited Export?

Letrozole — Export Intelligence Video

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Letrozole Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Letrozole Export Data from Intas Pharmaceuticals Limited

Letrozole Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source